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Abstract
Objective: Inflammatory response and metabolic
disturbances in coronary artery bypass grafting (CABG) with
cardiopulmonary bypass (CPB) and without (OFF-PUMP)
have been researched. Apoptosis in ischemic reperfusion and
chronic disease models has been shown in recent studies.
The objective of this study is to compare the apoptosis
intensity detected in cardiac myocytes before and after CABG
with and without cardiopulmonary bypass.
Method: Eighteen patients undergoing elective CABG
were divided in two groups: the first group underwent
cardiopulmonary bypasses and the second group did not.
Auricle myocardial samples were obtained at the beginning
and at the end of the surgery. Specimens were examined for
apoptosis using the TUNEL method.
Results: There was no significant difference between the
two groups in the surgical, demographic and postoperative
data. The number of grafts was statistically different. There
was no significant difference between the numbers of cells
undergoing apoptosis in the two groups at the beginning of
the procedure. There was no significant difference in the
number of cells undergoing apoptosis from the beginning to
the end of CABG in the OFF-PUMP group. There was a
significant difference between the number of cells undergoing
apoptosis at the beginning and the end of the CABG in the
CPB group (p<0.01).
Conclusion: The smaller number of cells undergoing
apoptosis in the OFF-PUMP group is in accordance with
published data that suggest CPB is capable of promoting cell
lesion. Having shown that, another favorable argument can
be added to the indication of the CABG without CPB.
Descriptors: Apoptosis. Cardiopulmonary bypass.
Coronary artery bypass grafting.
Resumo
Introdução: A resposta inflamatória e os distúrbios
metabólicos nas cirurgias de revascularização do miocárdio
(RM) com e sem circulação extracorpórea (CEC) têm sido
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INTRODUCTION
Comparisons of inflammatory responses and of metabolic
imbalance in coronary artery bypass grafting (CABG) with
and without cardiopulmonary bypass (CPB) have been
researched. Studies demonstrate the advantages in favor of
the use of off-pump surgery, that is, without CPB, both in
terms of the evolution and prognosis in correctly selected
patients [1,2].
Cardiovascular surgery may trigger a systemic
inflammatory response responsible for the dysfunction of
organs, which is observed in patients after cardiovascular
surgical procedures. Evidence suggests the involvement of
varying mediators in this mechanism [3].
CPB, by itself, might induce apoptosis. Patients submitted
to CPB have higher levels of fas and fas ligand expression
[4]. The serum of patients who underwent CPB is also capable
of inducing apoptosis in endothelial cell cultures [5].
Currently a new approach in investigations is being
explored, the study of the process of apoptosis and its
implications in several models of ischemia, ischemia/
reperfusion and chronic processes, in particular those
involving cardiomyocytes [6].
The investigations try not only to identify the triggering
mechanisms of the process, but also to create solutions
capable of reducing the lesions caused by apoptosis and,
consequently, strategies to reduce the loss of myocytes [6].
Apoptosis seems to be present in the human heart in
varying conditions such as in heart failure, myocardial
infarction, hibernating myocardium and it is induced during
open heart surgery, where it can contribute to lesions
provoked by ischemia/reperfusion as well as post-bypass
renal failure and brain failure [7].
Apoptosis is a type of programmed cell death which has
be described over the last decades as the main mechanism
of cellular turnover to maintain a cell-population balance in
all tissues. Contrary to other types of cell death, apoptosis
presents with morphological and biochemical
characteristics, which differentiate it from types of, cell death
such as necrosis [8].
Differently from necrosis, the process of apoptosis is
active, depending on the energy consumption and it is
dubbed as a precise regulating mechanism. Apoptosis plays
a fundamental role in the regulation of cellular proliferation,
whether in mature or in developing tissues [9-11]. Although
the process might be triggered by genetically established
triggers, other phenomenon and stimuli can activate it,
contributing to the physiopathology of several processes
of diseases [12,13].
Initially described in 1972 by KERR et al. [9], apoptosis
can be identified by molecular and biochemical
characteristics, however, morphological aspects observed
with electronic microscopes are the gold standard for its
identification [7].
Nevertheless, a biochemical characteristic, the
internucleosomal fragment of DNA, allowed an
immunocytochemical reaction to detect cells in apoptosis,
based on specific markers of the 3’-hydroxyl termination of
fragmented DNA, characteristics of cells in apoptosis, by
the addition of digoxigenin nucleotides by Terminal
Deoxynucleotidyl Transferase (TdT). This enzyme
catalyzes the addition of deoxyribonucleotide-triphosphate
to 3’-hydroxyl terminal portions of DNA fragments. After
incubation with anti-digoxigenin peroxidase, the reaction is
revealed by chromogenic reagents, such as diaminobenzidin
which causes the formation of a brown precipitate at the
site of the DNA breakpoint. This method commended by
GAVRIELI et al. [14] in 1992, is known as TUNEL (“Terminal-
transferase dUTP Nick End Labeling”) and allows detection
of the cells that are undergoing programmed cellular death.
 However, the TUNEL method can sometimes not be
completely specific in the marking of cells in apoptosis and,
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pesquisados. A apoptose vem sendo estudada em modelos de
isquemia, reperfusão e processos crônicos. O objetivo deste
trabalho é comparar o grau de apoptose detectada em
cardiomiócitos, antes e após a RM com e sem CEC.
Método: Dezoito indivíduos com indicação de RM, divididos
em dois grupos (CEC e OFF-PUMP), sendo o primeiro (CEC)
com o emprego da CEC e o segundo sem o auxílio desta
(OFF-PUMP), tiveram coletadas biópsias da aurícula direita,
ao início e ao término da operação. Os fragmentos foram
submetidos à marcação imunohistoquímica pelo método de
TUNEL e à contagem das células em apoptose.
Resultados: Não houve diferença entre os grupos nos dados
cirúrgicos, demográficos e pós-operatórios. O número de
pontes foi estatisticamente diferente. Não houve diferença
entre o número de células em apoptose nos grupos CEC e
OFF-PUMP, ao início do procedimento. O número de células
em apoptose não apresentou diferença significante entre o
início e o término do procedimento no grupo OFF-PUMP. O
número de células em apoptose, ao início e ao término da
operação, no grupo CEC apresentou diferença significante.
Conclusão: O menor número de células em apoptose
encontrado no grupo OFF-PUMP condiz com dados da
literatura que sugerem que a CEC é uma agressão à
homeostase e capaz de gerar lesão celular. Deste modo, mais
um argumento favorável pode ser agregado para a maior
indicação de RM sem o uso de CEC.
Descritores:  Apoptose. Ponte Cardiopulmonar.
Revascularização Miocárdica.
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consequently, some cells in necrosis and even the DNA or
RNA itself undergoing the repair process, can be positively
marked. Even electrophoresis of DNA might not be
completely specific to demonstrate the fragmentation
characteristic of DNA, as many non-cardiomyocyte cells
might be marked in the sample [15].
Although the TUNEL method is not the best manner to
semi-measure apoptosis of the cardiac myocytes, it is one
of our only tools. The frequency of positivity in several
studies demonstrates the dependence on diverse factors,
among which are the time of ischemia and the presence or
not of reperfusion [13,16].
Thus the aim of this work is to compare the degree of
apoptosis detected in cardiomyocytes, before and after
CABG with and without CPB.
METHOD
The Research Ethics Committee of the institution
approved the protocol of this study. Written consent was
obtained from all the patients included in the study. Eighteen
patients who underwent elective CABG, 9 with CPB and 9
off-pump were selected. The use or not of CPB was
determined by the experience of the surgical team as has
previously been described [1].
Re-operations, chronic renal failure, immunosuppression
and ejection fractions of less than 40% were considered
exclusion criteria.
Demographic, surgical, post- and intra-operative data
were collected.
Small samples of the right auricula of individuals in the
study were collected for biopsy at the start and end
(immediately before closure of the thoracic cage) phases of
the operation, taking care to avoid possible ischemic areas
caused by surgical manipulation such as at the site of CPB
cannulae.
The fragments were immediately fixed in 10% buffered
formalin. Fine 5-micrometer sections were placed on silanized
glass slides. The paraffin was removed from the samples
with xylol and re-hydrated with graduated concentrations
of ethanol. Subsequently, the samples were permeablized
with K proteinase and submitted to marking, according to
the instructions of the kit used (QIA33 – Calbiochem). A
counter-staining was made with methyl green. Negative
controls were produced by excluding the TdT reaction.
Measurements were performed by two experienced
‘blind’ examiners using histological image acquisition
software. The number of positively marked and the number
of non-marked cells at an amplification of 200x in six random
fields of view were counted on each slide, with one slide per
pre-operative sample and another per post-operative sample.
The data were submitted to statistical analysis using the
StatsDirect computer software. The Mann-Whitney and
Wilcoxon tests were utilized and a significance level of 5%
was used.
RESULTS
The individual characteristics researched did not
demonstrate statistically significant differences between the
two groups with the exception of the number of grafts, as is
shown in Table 1.
The mean percentages of the positively marked cells using
the TUNEL technique were as follows: Off-pump group pre-
operative 15.2%, Off-pump group post-operative = 16.4%, CPB
group pre-operative = 10.2% and CPB group post-operative =
20.4%. In the Off-pump group there was no statistically
significant difference between the samples collected at the start
and end of the surgery (p-value > 0.99). In the CPB group there
was a significant difference between the pre- and post-operative
groups (p-value = 0.03) (Figure 1).
The number of positively marked cells per field of view
in the four groups is demonstrated in Figure 2.
COMMENTS
This investigation demonstrated that the quantity of
cells evidenced by immunocytochemical markers for
apoptosis was significantly greater in the CPB post-
operative group when compared with the CPB pre-
operative group and with the Off-pump post-operative
group. These findings correspond with published results
that report the induction of apoptosis by cardioplegic
systems, ischemia and reperfusion and by systemic
inflammatory response due to CPB.
The percentage of positively marked cells found by the
reaction at the start of the operation in ischemic patients
agrees with previous publications [17].
Studies suggest that reperfusion, but not ischemia,
accelerates the apoptosis process and the fragmentation of
DNA [18]. Isolation of the individual components
responsible for the process seems a complicated task, as
several mediators are implicated in different steps of the
cascade that culminates in cellular destruction by apoptosis,
frequently triggered by distinct mechanisms and routes [13].
Their delimitation is still not clear, as is the role of each of
them and the exact location and mechanism of the action.
The choice of atrial fragment for the detection of
apoptosis also seems appropriate as it is supposed that the
phenomenon is the same in the entire heart [19].
The number of cells found in the atrial fragments might
seem relatively high and some factors contribute to this
finding. The use of K proteinase might increase the number
of false positive cases marked in the TUNEL test by the
liberation of endogen endonuclease [20]. The test might
not be specific for apoptosis too and cells in necrosis could
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Table 1. Characteristics of the patients and operative variables for the CPB and OFF-PUMP
groups (mean and standard deviation)
CPB – Cardiopulmonary Bypass
OTI – Orotracheal intubation
NA – Not applicable
NS – Without statistical significance (t-test)
S – Significant p-value = 0.008 (t-test)
ICU – Intensive Care Unit
Gender
Male
Female
Age
Arterial Hypertension
Systemic Arterial (number)
Diabetes Mellitus (number)
Dyslipidemia (number)
Ejection fraction (%)
Surgery time (min)
Tourniquet time (min)
CPB time (min)
Clamping time (min)
Number of grafts
Days in ICU
Use of vasoactive drugs
OTI time (min)
CPB
7
2
64,17 ± 11,17
6
2
3
63,8 ± 4,1
324,3 ± 54,2
NA
91,7 ± 28,7
62,0 ± 22,5
3,4 ± 1,0
2,3 ± 0,6
0
417,7 ± 175,3
OFF PUMP
5
4
62,89 ± 11,49
2
0
4
62,2 ± 5,9
309,3 ± 21,0
33,9 ± 7,5
NA
NA
2,2 ± 0,7
2,2 ± 0,7
0
326,1 ± 129,5
p-value
NS
NS
NS
NS
NS
NS
NS
NA
NA
NA
S
NS
NS
NS
Fig. 1 – A- Hematoxylin and Eosin stain. 100X. Myocardium with a normal aspect. Pre-operative Off-Pump group. B - TUNEL. 200X. Pre-
operative Off-Pump group. Observe the absence marked nuclei. C - TUNEL.400X. Post-operative CPB group. Observe the marked nucleus
(arrow).
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be TUNEL-positive [13]. On the other hand, there is reported
evidence of apoptosis without fragmentation of the DNA
[21].
Another fact to be considered is that many non-
cardiomyocyte cells, such as endothelial cells, microphages,
myofibroblasts and neutrophil infiltration could be being
marked and increasing the global cell count [13].
The test used in this study is not a definitive and exact
manner to detect apoptosis and other forms of detection
can be used in combination with it for a more precise
estimation of the number of cardiomyocytes involved and
subject to this phenomenon.
However, in our study, two groups were compared with
similar characteristics and submitted to the same histological
preparation and, thus, possibly subject to the same risks of
overestimation of the number of positively marked cells by
the TUNEL technique. Thus, the difference between the
groups should be maintained if other more specific methods
of measurement are employed.
Hence, this is not a conclusive study, however we
suggest that the use of CPB in CABG surgeries is capable
of inducing apoptosis in a greater number of cells, when
compared to Off-pump CABG.
To reduce apoptosis seems to be a good way of reducing
cardiac lesions provoked by ischemia/reperfusion and
systemic inflammatory responses to CPB [7]. However, the
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